Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

COVID-19

Free Subscription 03.11.2025 5 Clin Infect Dis 2 Int J Infect Dis 3 J Infect 3 J Med Virol 3 J Virol 4 JAMA 1 Lancet 2 Lancet Infect Dis 1 N Engl J Med 1 Nature 1 Pol J Radiol 2 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Infect Dis

1. CALABRESE C, Wang Y, Duggal A, Huang S, et al
   Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation Study.
   Clin Infect Dis. 2025 Oct 24:ciaf521. doi: 10.1093.
   PubMed         Abstract available
   
   
2. FONG Y, Huang Y, Huang Y, Woo W, et al
   Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine.
   Clin Infect Dis. 2025 Oct 25:ciaf558. doi: 10.1093.
   PubMed         Abstract available
   
   
3. KABORE JL, Laffont B, Diop M, Tardif MR, et al
   Real-World Effectiveness of Nirmatrelvir-Ritonavir in Preventing Coronavirus Disease 2019-Associated Hospitalization: A Population-Based Cohort Study in the Province of Quebec, Canada.
   Clin Infect Dis. 2025 Oct 29:ciaf145. doi: 10.1093.
   PubMed         Abstract available
   
   
4. 
   Retraction and replacement of: Real-World Effectiveness of Nirmatrelvir/Ritonavir on Coronavirus Disease 2019-Associated Hospitalization Prevention: A Population-based Cohort Study in the Province of Quebec, Canada.
   Clin Infect Dis. 2025 Oct 29:ciaf144. doi: 10.1093.
   PubMed        
   
   
5. RATTANAPITOON NK, La N, Thanchonnang C, Rattanapitoon SK, et al
   Recalibrating COVID-19 Booster Policy: Lessons From Hybrid Immunity and Global Equity Gaps.
   Clin Infect Dis. 2025 Oct 31:ciaf605. doi: 10.1093.
   PubMed        
   
   

   
   Int J Infect Dis

6. MARKING U, Wahlstrom E, Holm J, Walther S, et al
   Risk factors for hospitalisation and death due to COVID-19 during endemic Omicron circulation, a population-based cohort study.
   Int J Infect Dis. 2025 Oct 27:108156. doi: 10.1016/j.ijid.2025.108156.
   PubMed         Abstract available
   
   
7. ZHANG S, Yang M, Zhou W, Yao Y, et al
   Changes of Dynamics of Influenza before and after COVID-19 Pandemic: A Global Study in Eight Regions.
   Int J Infect Dis. 2025 Oct 29:108173. doi: 10.1016/j.ijid.2025.108173.
   PubMed         Abstract available
   
   

   
   J Infect

8. HAN S, Liu Y, Xing B, Yang Y, et al
   Association of Glucagon-Like Peptide-1 Receptor Agonist Use with Risk of Infections: A Systematic Review and Meta-analysis.
   J Infect. 2025 Oct 29:106645. doi: 10.1016/j.jinf.2025.106645.
   PubMed         Abstract available
   
   
9. ZHAN JY, Ren L, Li CK, Zhong L, et al
   Exhausted KLRG1(hi) CD8(+) T and Pathogenic GZMA(+) Th17 Cells Are Associated with the Mild Mycoplasma pneumoniae Pneumonia in Children.
   J Infect. 2025 Oct 29:106642. doi: 10.1016/j.jinf.2025.106642.
   PubMed         Abstract available
   
   
10. SANO K, Kimura Y, Hirahata K, Kato H, et al
    SARS-CoV-2 spike-specific IgG4 class switching associates with clinical recovery in Long COVID.
    J Infect. 2025 Oct 23:106641. doi: 10.1016/j.jinf.2025.106641.
    PubMed        
    
    

    
    J Med Virol

11. YUAN L, Wang B, Huang YW
    Regulation of Apoptosis and PANoptosis by Coronavirus: An Overview.
    J Med Virol. 2025;97:e70672.
    PubMed         Abstract available
    
    
12. DALEXIS RD, Xu Y, Moshirian Farahi SMM, Beogo I, et al
    COVID-19 Vaccine Mistrust, Racial Discrimination, and Conspiracy Beliefs Among Parents in Canada: Implications for Public Health.
    J Med Virol. 2025;97:e70673.
    PubMed         Abstract available
    
    
13. CHEN R, Hui KPY, Nicholls JM, Ip MSM, et al
    Cigarette Smoke Deteriorates SARS-CoV-2 Infection-Induced Lung Injury.
    J Med Virol. 2025;97:e70671.
    PubMed         Abstract available
    
    

    
    J Virol

14. DETTE A, Moers F, Mayr T, Stillfried Sv, et al
    Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19.
    J Virol. 2025 Oct 29:e0138425. doi: 10.1128/jvi.01384.
    PubMed         Abstract available
    
    
15. JOHNSON KEE, Stein S, Boateng RA, Jain S, et al
    Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19.
    J Virol. 2025 Oct 31:e0085725. doi: 10.1128/jvi.00857.
    PubMed         Abstract available
    
    
16. ZHANG D, Yuan Y, Hu G, Xie Y, et al
    Engineering a TGEV S-trimer chimera with PEDV D0-NTD generates potent neutralizing antibodies against both viruses.
    J Virol. 2025 Oct 31:e0145225. doi: 10.1128/jvi.01452.
    PubMed         Abstract available
    
    

    
    JAMA

17. WILSON KT, Esposito ML, Martinez A
    Life Expectancy After the COVID-19 Pandemic.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.16403.
    PubMed        
    
    
18. ABBASI J
    New Guidance on Cardiovascular Disease and COVID-19-From Infection to Long COVID to Vaccination.
    JAMA. 2025 Oct 24. doi: 10.1001/jama.2025.18834.
    PubMed        
    
    
19. SCHWANDT H, Kowarski J, Woolf SH
    Life Expectancy After the COVID-19 Pandemic-Reply.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.16405.
    PubMed        
    
    
20. PANT S
    First-Trimester COVID-19 Vaccination Not Associated With Congenital Risks.
    JAMA. 2025 Oct 31. doi: 10.1001/jama.2025.17533.
    PubMed        
    
    

    
    Lancet

21. SEDKY J, Gardner A, Ivers LC
    Loans dominated COVID-19 funding: it's time to adjust.
    Lancet. 2025;406:1946.
    PubMed        
    
    

    
    Lancet Infect Dis

22. BAGER P, Svalgaard IB, Christiansen LE, Lomholt FK, et al
    COVID-19 versus influenza burden in Denmark in the 2024-25 season.
    Lancet Infect Dis. 2025 Oct 27:S1473-3099(25)00604.
    PubMed        
    
    
23. SYMES R, Whitaker HJ, Ahmad S, Arnold D, et al
    Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75-79 years in England: a multicentre, test-negative, case-control study.
    Lancet Infect Dis. 2025 Oct 27:S1473-3099(25)00546.
    PubMed         Abstract available
    
    

    
    N Engl J Med

24. SCOTT J, Abers MS, Marwah HK, McCann NC, et al
    Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026.
    N Engl J Med. 2025 Oct 29. doi: 10.1056/NEJMsa2514268.
    PubMed         Abstract available
    
    

    
    Nature

25. SMITH J
    Daily briefing: People with cancer lived longer if they'd had a COVID-19 vaccine.
    Nature. 2025 Oct 23. doi: 10.1038/d41586-025-03496.
    PubMed        
    
    

    
    Pol J Radiol

26. RIZZETTO F, Berta L, Zorzi G, Travaglini F, et al
    Optimising strategies for artificial intelligence-assisted classification of viral pneumonias on CT imaging: a comparative study of selective and default approaches.
    Pol J Radiol. 2025;90:e384-e393.
    PubMed         Abstract available
    
    

    
    Science

27. BRETT TS, Rohani P
    Collateral effects of COVID-19 pandemic control on the US infectious disease landscape.
    Science. 2025;390:510-515.
    PubMed         Abstract available
    
    
28. DURRHEIM DN
    Broad benefits of the COVID-19 pandemic response.
    Science. 2025;390:442.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.